This information was provided by prnewswire
Send your Press Release here.
KELOWNA, BC, Oct. 3, 2018 /CNW/ – Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) (“Marapharm” or the “Company”) is very pleased to announce, the Company has submitted the necessary amendments to its late-stage, Health Canada’s Access to Cannabis for Medical Purposes Regulations(“ACMPR”) application.
The Company is honored that Mr. Gabriel Cipes has accepted the appointment of Head of Quality Assurance and has approved the Company’s amendments to the Quality Assurance portion of its application.
Mr. Cipes is Vice President of Summerhill Pyramid Winery, one of the largest certified organic wineries in Canada. In 2010, he created the biodynamic and permaculture department at the winery which has been a major aspect of Summerhill’s ‘Organic’ branding and story, achieving the first certified Demeter vineyard in western Canada.
Mr. Cipes conducts Scientific Research & Experimental Development (SRED) developing polycultural management strategies to prove that one can not only produce diversified yields but also benefit the environment through incorporating biodiversity.
He has been developing and advising departments of environmental best practices such as waste water re-capture, ground water restoration strategies, recycling, composting and maintaining the zero waste principles and ethics.
Mr. Cipes serves on several organic and biodynamic certification boards such as, Demeter Canada, the Biodynamic Associations of BC (BDASBC) and the Certified Organic Associations of BC (COABC) where he provides oversight for all Certification Bodies (CB`s) in BC and oversees certification programs, Canadian Organic Regime (COR) and the BC Certified Organic Program (BCCOP).
“I feel honored to work with the mother herb and this Company. We are guided by holistic principles to ensure the highest quality and vibration of the medicine we will produce.” Gabriel Cipes
The Company has amended its location to a 40-acre site in Celista, BC, where (10) – 10,000 sq. ft, fully-funded, bio-secure engineered facilities will be constructed in two phases; maximizing our potential of a 100,000 sq. ft. ACMPR licence, once approved by Health Canada.
Ground preparation is now complete and building components have arrived on site.